Inhibition of prostate cancer cell PC-3 by rAd-ODC/Ex3as

张岩,刘贤锡,胡海燕,王晓明,张冰,龚磊
DOI: https://doi.org/10.3969/j.issn.1671-7554.2004.05.006
2004-01-01
Abstract:Objective: To study the effects of rAd-ODC/Ex3as on prostate cancer cells in vitro and explore its effecting mechanism. Methods: The infection rate of rAd-ODC/Ex3as was measured with the aid of GFP expression. Western Blot technique was used to observe the inhibition of ODC in infected tumor cells. The malignant phenotype of PC-3 cells was assessed by growth curve and Matrigeal invasion assay respectively, and flow cytometry was used to analyze cell cycle progress and apoptosis. Results: Approximate 70% of PC-3 cells were infected with rAd-ODC/Ex3as when MOI reached 50. The expression of ODC was inhibited in the infected tumor cells. rAd-ODC/Ex3as could inhibit cell growth and invasive ability at 20 MOI. Meanwhile, flow cytometry proved that rAd-ODC/Ex3as led the infected cells to arrest at G1 phase but had no effect on apoptosis. Conclusion: rAd-ODC/Ex3as can suppress the proliferation and invasive ability of prostate cancer cells, and induce G1 arrest. It may be one of the promising medicines for antisense gene therapy in prostate cancer.
What problem does this paper attempt to address?